Acute immune hemolysis induced by a degradation product of amphotericin B
- 1 February 1989
- journal article
- research article
- Published by Springer Science and Business Media LLC in Blut: Zeitschrift für die Gesamte Blutforschung
- Vol. 58 (2), 59-61
- https://doi.org/10.1007/bf00320648
Abstract
We report here on an eight-year-old boy who first developed acute intravascular hemolysis following therapy with amphotericin B (AmB) and subsequently a delayed hemolytic transfusion reaction due to alloantibodies. Although there is as yet no evidence for metabolism of AmB in vivo, the hemolysis appeared to be the result of sensitization against a degradation product of the drug. The patient's serum contained a hemagglutinating IgM antibody that reacted with all red blood cells (RBC) tested in the presence of plasma obtained from patients receiving AmB (ex vivo antigen), but not in the presence of their urine, AmB itself, or with AmB-pretreated RBC. These findings indicate that the antibody was directed against a degradation product of AmB, presumably a trace metabolite, that has not yet been identified.Keywords
This publication has 11 references indexed in Scilit:
- Metabolite‐specific (IgG) and drug‐specific antibodies (IgG, IgM) in two cases of trimethoprim‐sulfamethoxazole‐induced immune thrombocytopeniaTransfusion, 1987
- On the mechanisms of sensitization and attachment of antibodies to RBC in drug-induced immune hemolytic anemia.1987
- On the mechanisms of sensitization and attachment of antibodies to RBC in drug-induced immune hemolytic anemiaBlood, 1987
- Distribution and Activity of Amphotericin B in HumansThe Journal of Infectious Diseases, 1985
- The Role of Metabolite-Specific Antibodies in Nomifensine-Dependent Immune Hemolytic AnemiaNew England Journal of Medicine, 1985
- Delayed hemolytic transfusion reactions. Evidence for complement activation involving allogeneic and autologous red cellsTransfusion, 1984
- A Review of Complications of Amphotericin-B Therapy: Recommendations for Prevention and ManagementDrug Intelligence & Clinical Pharmacy, 1980
- Amphotericin B Pharmacokinetics in HumansAntimicrobial Agents and Chemotherapy, 1978
- Immune thrombocytopenia due to a metabolite of para-aminosalicylic acidAmerican Journal Of Medicine, 1972
- Amphotericin B serum concentrations during therapy.1970